Dr Michele Barbour

Research summary

I am the head of the Oral Nanoscience research group.

Our primary research interests are the development, characterisation and application of multifunctional clinical nanomaterials. Of particular interest are antimicrobial and antifungal technologies.

We are currently developing a novel antmicrobial technology based on chlorhexidine, which can be used in a wide range of dental and medical materials and devices. The technology is the subject of two patent applications and the development is supported by research council and Innovate UK funding. 

Read more >

Biography

I am Reader in Biomaterials and Deputy Head of Bristol Dental School. I am also the founder and CEO of a University of Bristol spin-out company, Pertinax Pharma Ltd.

I graduated from the University of Oxford in 1998 with an MPhys (undergraduate physics degree) and the University of Bristol with a PhD in 2003. 

Read more >

Recent publications

• Duckworth, PF, Rowlands, RS, Barbour, ME & Maddocks, SE, 2018, ‘A novel flow-system to establish experimental biofilms for modelling chronic wound infection and testing the efficacy of wound dressings’. Microbiological Research, vol 215., pp. 141-147
• Bellis, CA, Addison, O, Nobbs, AH, Duckworth, PF, Holder, JA & Barbour, ME, 2018, ‘Glass ionomer cements with milled, dry chlorhexidine hexametaphosphate filler particles to provide long-term antimicrobial properties with recharge capacity’. Dental Materials.

Read more >

View complete publications list in the University of Bristol publications system